Marshall Horwitz
Has grant
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Marshall Horwitz is a Professor at the University of Washington School of Medicine in the United States. His research focuses on the role of neutrophil elastase and its related genetic mutations, particularly in relation to granulocytic differentiation. Recent publications include discussions on the implications of ELANE mutations and their effect on protein processing within cells.
Recent Grants
Grant: Close
Pathogenesis of ELANE-Associated Neutropenia
Open Date: 2016-01-15
Close Date: 2019-11-30
Grant: Close
Translational Control in Bone Marrow Failure
Open Date: 2013-05-01
Close Date: 2016-04-30
Grant: Close
Genomic Fate Maps
Open Date: 2008-02-01
Close Date: 2015-01-31
Grant: Close
NIH Director's Pioneer Award
Open Date: 2007-09-30
Close Date: 2014-07-31
Grant: Close
Mistargeting of Elastase in Bone Marrow Failure
Open Date: 2004-09-30
Close Date: 2010-07-31
Articles (9)
Year:
2026
Year:
2026
Advancements in genetics and genomics continue to further our understanding of their contributions to the development of interstitial lung diseases (ILDs). This state-of-the-art clinical review synthesises current knowledge of the contribution of genetics when evaluating patients suspected to have ILD. We consider highly penetrant Mendelian disorders as well as common variants conferring smaller risk that act in concert with other genetic and acquired risk factors. Additionally, gene-by-environment and pharmacogenomic interactions are discussed to highlight their impact on disease course. Lastly, the approach to genetic ILDs is reviewed from available testing to future directions.
Year:
2025
Pathogenic/likely pathogenic (P/LP) germline variants in RUNX1 cause familial platelet disorder with associated myeloid malignancies (FPDMM), also known as RUNX1- Familial Platelet Disorder (RUNX1-FPD, or FPD), a condition characterized by qualitative and quantitative platelet defects and predisposition to hematopoietic malignancies. Here, we present follow up to a case of a woman with acute myeloid leukemia and lifelong thrombocytopenia which had previously been attributed to presumptive pathogenic (P) GATA2 missense variants. However, re-evaluation with updated molecular technology sensitive for detection of copy number variants (CNVs) led to the identification of a P deletion of exons 5-6 in RUNX1 , which had been undetected when examined at first presentation. This case highlights the importance of comprehensive molecular evaluation and careful variant interpretation, especially regarding CNVs.
Year:
2025
Year:
2025
Objective Mitochondrial DNA (mtDNA) depletion/deletions syndrome (MDDS) comprises a group of diseases caused by primary autosomal defects of mtDNA maintenance. Our objective was to study the etiology of MDDS in 4 patients who lack pathogenic variants in known genetic causes. Methods Whole exome sequencing of the probands was performed to identify pathogenic variants. We validated the mitochondrial defect by analyzing mtDNA, mitochondrial dNTP pools, respiratory chain activities, and GUK1 activity. To confirm pathogenicity of GUK1 deficiency, we expressed 2 GUK1 isoforms in patient cells. Results We identified biallelic GUK1 pathogenic variants in all 4 probands who presented with ptosis, ophthalmoparesis, and myopathic proximal limb weakness, as well as variable hepatopathy and altered T‐lymphocyte profiles. Muscle biopsies from all probands showed mtDNA depletion, deletions, or both, as well as reduced activities of mitochondrial respiratory chain enzymes. GUK1 encodes guanylate kinase, originally identified as a cytosolic enzyme. Long and short isoforms of GUK1 exist. We observed that the long isoform is intramitochondrial and the short is cytosolic. In probands’ fibroblasts, we noted decreased GUK1 activity causing unbalanced mitochondrial dNTP pools and mtDNA depletion in both replicating and quiescent fibroblasts indicating that GUK1 deficiency impairs de novo and salvage nucleotide pathways. Proband fibroblasts treated with deoxyguanosine and/or forodesine, a purine phosphatase inhibitor, ameliorated mtDNA depletion, indicating potential pharmacological therapies. Interpretation Primary GUK1 deficiency is a new and potentially treatable cause of MDDS. The cytosolic isoform of GUK1 may contribute to the T‐lymphocyte abnormality, which has not been observed in other MDDS disorders. ANN NEUROL 2024;96:1209–1224
Year:
2024
Purpose Complex chromosomal rearrangements (CCRs) are rare structural variants involving three or more chromosomal breakpoints. Most de novo reported CCRs pose challenges for diagnosis and management. They often require karyotyping, fluorescence in situ hybridization (FISH), and chromosomal microarray analysis (CMA) for clinical diagnosis because of the limitations of each method. Here we report an inherited exceptionally complex CCR involving 4 chromosomes and 11 breakpoints in a family with multisystem anomalies. Methods We evaluated the CCRs using karyotyping, FISH, CMA, and two emerging genomic technologies: high-throughput chromosome conformation capture sequencing (Hi-C; aka genomic proximity mapping, GPM) and optical genome mapping (OGM). We also performed functional studies using transcriptome and methylome analyses. Results The proband, who had intellectual disability and immune deficiency, shared CCRs with her unaffected mother involving chromosomes 1, 7, and 11 by karyotyping. However, CMA revealed a duplication and three deletions in the proband in contrast to her mother’s balanced genome. Hi-C (GPM) and OGM detected the CCRs and copy number alterations but also uncovered additional breakpoints at high resolution, including an insertion in 4p and two cryptic rearrangements at 7p. Transcriptome and methylome analyses identified likely biological pathways associated with the proband’s phenotypes. Conclusion Combining cytogenetic and genomic methods provided comprehensive characterization and defined the breakpoints at high resolution in both proband and mother. This underscores the value of novel cytogenetic and genomic techniques in deciphering complex genome rearrangements and the significance of integrative genomic analysis and functional characterization in understanding clinical phenotypes.
Year:
2024
Year:
2021
Year:
2020
Collaborators (13)
Shuang Wang
Professor of Biostatistics
Columbia University
Glòria Garrabou
University of Barcelona
He Fang
Assisstant Professor
University of Washington
Kurenai Tanji
Professor
Columbia University
Patrick Hu
Director, Medical Scientist Training Program
University of Colorado Anschutz Medical Campus
Mahesh Mansukhani
Professor
Columbia University Irving Medical Center
David Zhang
Assistant Professor
Columbia University Irving Medical Center
Raphael Borie
Praticien Hospitalier
INSERM
Dario Ronchi
Associate Professor
University of Milan
Michio Hirano
Assistant/Associate/Full Professor
Columbia University Irving Medical Center
Hamish Scott
University of South Australia
Giacomo Comi
Professore Ordinario
Università degli Studi di Torino
Antonia Ribes Rubio
Head of the Section of Inborn Errors of Metabolism
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Make your next move.
Prepare your application
Review drafts before you send them.